(Q39903765)

15 September 2017

1 reference

title

Pseudomonas aeruginosa infections. (English)

1 reference

15 September 2017

Pseudomonas aeruginosa

0 references

author name string

Young LS

series ordinal

1

1 reference

PubMed ID

4376736

15 September 2017

Armstrong D

series ordinal

2

1 reference

15 September 2017

1 September 1972

1 reference

CRC critical reviews in clinical laboratory sciences

15 September 2017

1 reference

15 September 2017

3

1 reference

15 September 2017

3

1 reference

15 September 2017

291-347

1 reference

The Changing Pattern of Life-Threatening Microbial Disease

15 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Death after transplantation; an analysis of sixty cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Studies of a patient isolator unit and prophylactic antibiotics in cancer chemotherapy. General techniques and preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Cross-infection by Pseudomonas aeruginosa as a hazard of intensive surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Leukocyte function in chronic granulomatous disease of childhood. Studies on a seventeen year old boy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

HYPOGAMMAGLOBULINAEMIA PRESENTING AS PSEUDOMONAS SEPTICAEMIA

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

TREATMENT OF LARGE HUMAN BURNS WITH 0.5 PER CENT SILVER NITRATE SOLUTION.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Significance of Selective Vasculitis and the Bone-Marrow Syndrome in Pseudomonas Septicemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Serogroups of Pseudomonas aeruginosa and the Immune Response of Patients with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Opsonic defect in patients with cystic fibrosis of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Characteristics of nonbacteremic Pseudomonas pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Bacteraemia in patients receiving human cadaveric renal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Pseudomonas meningitis related to spinal anesthesia. Report of three cases with a common source of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Successful treatment of osteomyelitis caused by Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

An outbreak of Pseudomonas aeruginosa (pyocyanea) infection in a Premature Baby Unit, with observations on the intestinal carriage of Pseudomonas aeruginosa in the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Pseudomonas aeruginosa epidemic traced to delivery-room resuscitators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Pseudomonas aeruginosa in dermatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Pseudomonas infections of the foot following puncture wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Observations on bacteriophage typing of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Further Studies In The Pyocine Typing Of Pseudomonas Pyocyanea

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

THE PRODUCTION AND INACTIVATION OF PYOCINES.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Pseudomonas aeruginosa in a center for cancer research. I. Distribution of intraspecies types from human and environmental sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Changes in somatic antigens of Pseudomonas aeruginosa induced by bacteriophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Faecal carriage of Pseudomonas aeruginosa in hospital patients. Possible spread from patient to patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

The epidemiology of infection with Pseudomonas pyocyanea in a burns unit

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

PYOCINE-TYPING OF HOSPITAL STRAINS OF PSEUDOMONAS PYOCYANEA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Colonisation of the upper respiratory tract with Gram-negative bacilli after operation, endotracheal intubation and prophylactic antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

THE POTENTIAL ROLE OF INHALATION THERAPY EQUIPMENT IN NOSOCOMIAL PULMONARY INFECTION

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

HOSPITAL INFECTION WITH PSEUDOMONAS AERUGINOSA IN NEUROSURGERY.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Survival of Pseudomonas aeruginosa in the hospital environment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Antibiotics for Pseudomonas aeruginosa sepis: inadequate proof of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Carbenicillin Therapy for Pseudomonas Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Pseudomonas Vaccine and Hyperimmune Plasma for Burned Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Evaluation of methods for determining antibacterial activity of serum and urine after colistimethate injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

In-vivo effectiveness of the antibiotic colistin in preventing growth of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Gentamicin and colistin in chronic purulent bronchial infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

GENTAMICIN IN GRAM-NEGATIVE URINARY AND PULMONARY INFECTIONS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

LABORATORY AND CLINICAL STUDIES OF GENTAMICIN, A NEW BROAD-SPECTRUM ANTIBIOTIC.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Ecology of Bacteria Colonizing the Burned Patient Given Topical and Systemic Gentamicin Therapy: A Five-Year Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Use of Gentamicin in Children with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Gentamicin in Pediatrics. I. Report on Intrathecal Gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Carbenicillin: Clinical and Laboratory Experience with a Parenterally Administered Penicillin for Treatment of Pseudomonas Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Carbenicillin: A Clinical and Laboratory Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Carbenicillin therapy of Pseudomonas and other gram-negative bacillary infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Resistance of Pseudomonas aeruginosa to carbenicillin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Beta-lactamase and the resistance of Pseudomonas aeruginosa to various penicillins and cephalosporins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Intergeneric Transfer of a β-Lactamase Gene between Ps. aeruginosa and E. coli

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

R-factor mediated β-Lactamase in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

The Use of Combinations of Antimicrobial Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Carbenicillin and Gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Combined Use of Gentamicin and Carbenicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Endotoxins and bacterial virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. II. Effects of lecithinase and protease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Slime production by Pseudomonas aeruginosa. I. Conditions for slime production by the cellophane plate method.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

The Roles of Various Fractions of Pseudomonas aeruginosa in Its Pathogenesis: III. Identity of the Lethal Toxins Produced in Vitro and in Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Pseudomonas exotoxin shock. A preliminary report of studies in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Cyanide production by pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

The Serum Bactericidal Reaction. IV. Phenotypic Conversion of Escherichia coli From Serum-resistance to Serum-sensitivity by Diphenylamine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Immunity and antibody to Pseudomonas pyocyanea in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

GROWTH, TOXIGENICITY AND VIRULENCE OF PSEUDOMONAS AERUGINOSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

ASSOCIATION OF "NATURAL" ANTIBODIES TO GRAM-NEGATIVE BACTERIA WITH THE γ1-MACROGLOBULINS

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Neutrophil Function in Selected Surgical Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

The effects of the morphine analogue levorphanol on leukocytes. Metabolic effects at rest and during phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

The effect of an NADH oxidase inhibitor (hydrocortisone) on polymorphonuclear leukocyte bactericidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Susceptibility of man to Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Effect of antilymphocyte serum on mortality of pseudomonas aeruginosa-infected rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Observations on the antigenic structure of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

"Abacterial" and bacterial pyelonephritis. Immunofluorescent localization of bacterial antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Bacterial precipitins in serum of patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Immunization Against Pseudomonas aeruginosa: I. Induction of Protection by an Alcohol-Precipitated Fraction from the Slime Layer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Experimental infection with Pseudomonas aeruginosa in mice. I. The virulence of Pseudomonas aeruginosa for mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Prevention of invasive pseudomonas infection in burns with a new vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Intraleukocytic microbicidal defects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Convalescent Burn Plasma Therapy for Severely Burned Children Control Study of 81 Cases and Tests for Pseudomonas Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

Hospital-acquired infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10408367209151698

10.3109/10408367209151698

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference

PubMed ID

4376736